Popis: |
The side effects encountered with the intravenous administration of methohexital sodium (Brevital), using a maximum of 60 mg during 1 hr treament sessions, are reported for 17 neurotic patients treated with Brevital-aided desensitization. It is concluded, that while side effects are moderately common, they are so mild as to pose no significant treatment obstacle. The drug is sufficiently safe, at low dosages, to allow in vivo treatment with rapid re-exposure to anxiety-eliciting stimuli without causing the patients undue distress. |